The Global Alzheimer's Platform Foundation(R) (GAP) is pleased to welcome Spear Bio, a biotechnology company pioneering wash-free ultrasensitive immunoassay technology, to the Bio-Hermes-002 study.
"CGIE (TM) is being built as future-facing infrastructure rather than a point solution," said Yusuf Henriques, Founder and CEO of IndyGeneUS Bio. "Our objective is to establish the AI×Bio Factory--the ...
Recently, ‘biological age’ tests have been gaining popularity in Silicon Valley, the United States. These tests measure ...
IndyGeneUS Bio today announced the filing of a patent application covering its Clinico-Genomic Insight Engine™ ...
Researchers working on the Leonardo da Vinci DNA Project believe the Renaissance Man left his DNA on the chalk drawing titled ...
Learn how spectroscopy facilitates non-invasive, real-time bio-monitoring, enhancing decision-making in healthcare, ...
FairJourney Bio (FJBio), a leading global provider of antibody discovery and development services, today announced the ...